Head-to-head · WeighScore
Marek Health vs NuuVim
The verdict
NuuVim takes it — 68.2/100 to 66.9/100, but only just.
NuuVim grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuuVim is a Texas-based DTC telehealth program offering compounded semaglutide and tirzepatide in both injectable and oral forms — oral access is uncommon here — plus limited brand-name Ozempic and Zepbound. Marek Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Marek Health | NuuVim |
|---|---|---|
| WeighScore | 66.9/100 | 68.2/100 |
| Grade | C | C |
| Scorecard rank | #173 | #153 |
| Semaglutide | Not disclosed | $79/mo (all doses, 3-mo plan, new patients only, compounded) |
| Tirzepatide | Not disclosed | $133/mo (all doses, 3-mo plan, new patients only, compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #173 · C
Strengths
- Lab panels are core: initial comprehensive labs + 6–12 week follow-up + ongoing every 6 months — rare among GLP-1 providers
- Dedicated Health Coach paired with each client alongside partnered licensed physician as standard Proactive Care Team
- All 50 US states served; 100% telehealth with routine physician check-ins every 6 months built into the program
- Human optimization framing attracts pragmatic patients; partnered physicians selected for data-driven, high-leverage mindset
- No set subscription plan — custom protocol built around client health goals with option to cancel anytime
Where it loses points
- Pricing fully gated — no published rates; intake assessment required before quotes, limiting upfront comparison shopping
- Annual in-person physical required from own PCP or urgent care (every 12 months) — not provided by Marek Health
- No LegitScript certification found; platform explicitly disclaims being a healthcare clinic, which reduces regulatory trust signals
- Weight loss is one of many services alongside TRT, hair, brain focus, sexual health — not a dedicated GLP-1 platform
- Compounded vs. brand medication details not disclosed publicly — medication type determined post-intake with partnered physician
Graded #153 · C
Strengths
- Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
- Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
- LegitScript Certified and HIPAA-compliant
- Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
- Operating legal entity disclosed: NuuVim LLC, Texas governing law
Where it loses points
- There is no month-to-month plan: every rate is billed as one three-month payment
- The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
- The site's own llms.txt advertises pricing, FAQ and terms files that all 404
- No state count is published
- FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.